Among the 85 patients who progressed to CRPC, and 152 patients who did not progress to CRPC, the levels of NRG1 in serum and biopsy tissues, as well as the relative NRG1 mRNA levels in tumor tissue, were detected before the initiation of ADT. The gene discussed is NRG1; the disease is neoplasm.